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Distinct and Nonredundant In Vivo Functions of TNF
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for resistance to an intracellular pathogen, Listeria,
whereas T-cell-derived TNF was important for protec-
tion against high bacterial load. Additionally, both
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system and a knockin/transgenic approach. We first sis and intracellular cytokine staining revealed high effi-
ciency and specificity of TNF ablation in T lymphocytesgenerated the knockin TNFflox/flox mice (Figure 1A) in
which the TNF gene was modified by the insertion of (Figures 1E and 2F). In particular, T-TNF KO mice were
characterized by almost complete deletion of the genetwo synthetic loxP sites flanking the critical coding re-
gion and placed in such a way as to leave the TNF gene in thymus. Purified splenic T cells exhibited 98% of
deletion, and intracellular staining of TNF revealed thatfully functional. We rigorously verified that the insertion
of the loxP sites into the TNF gene did not change the CD3 splenocytes from T-TNF KO mice activated with
PMA/ionomycin failed to produce any detectable TNF.wild-type phenotype of TNFflox/flox mice (for details, see
Figure 1A and Supplemental Figure S4 at http://www. On the other hand, BMDC from T-TNF KO mice pro-
duced normal amounts of TNF in response to LPS (Fig-immunity.com/cgi/content/full/22/1/93/DC1/).However, in
these mice the TNF gene was tagged for subsequent ure 2G).
To generate B-cell-specific TNF KO mice, we utilizeddeletion by Cre recombinase expressed under cell-lin-
eage-specific or inducible promoters. CD19-Cre deleter mice (Rickert et al., 1997), which were
previously used to inactivate the neighboring LT geneIn order to generate mice with specific deletion of
the TNF gene in macrophages and granulocytes, we with a high efficiency and specificity (Tumanov et al.,
2002). B-TNF KO mice showed approximately 99% TNFcrossed TNF floxed mice with knockin LysMcre mice
bearing Cre recombinase under the control of the lyso- gene deletion in B cells but no detectable deletion in
either macrophages, thymus, kidney, or liver (Figureszyme M promoter (Clausen et al., 1999; Faust et al.,
2000). For the experiments, we usedmicewith the geno- 1F, 1G, and 2F).
Finally, we verified that complete loxP-mediated dele-type tnf flox/flox lysMCre/wt, which were named MN-TNF KO
mice (Figure 1A). The extent of TNF gene deletion was tion of the TNF gene did not affect the expression of
LT or LT in spleen and on activated splenocytes (Sup-almost complete in neutrophils and macrophages
(98%), whereas nonewas detected in liver and thymus plemental Figure S4B). Splenic structure in complete
TNFKOmice was reminiscent of that in the conventional(Figures 1B–1D). TNF mRNA in bone-marrow-derived
macrophages (BMDM) was barely detectable by North- TNF KO mice (Pasparakis et al., 1996, 2000; Korner et
al., 1997) and was clearly distinct from LT KO miceern analysis after lipopolysaccharide (LPS) stimulation,
in contrast to high levels of TNF transcripts in cells from (Supplemental Figure S4A).
control mice (Figure 2A). Virtually no TNF protein was
detected in supernatants of neutrophils from MN-TNF Deleterious TNF Can Be Produced by Various Cell
Types, Depending on the Toxicity ModelKO mice stimulated with LPS (Figure 2B). Production of
TNF by peritoneal-elicited cells (PEC) from MN-TNF KO Bacterial products induce innate immunity by engaging
Toll-like receptors (TLRs) (Medzhitov and Janeway,mice stimulated in vitro by LPS was significantly re-
duced (Figure 2C). Finally, intracellular cytokine staining 1997). TNF production is an important downstream tar-
get of TLR signaling, in particular through TLR4 (Poltorakof CD11b PEC treated with LPS revealed a dramatic
reduction in TNF levels in cells from MN-TNF KO mice et al., 1998). As such, TNF was reported to be a critical
mediator of septic shock in humans and of LPS/D-Gal-in comparison to wild-type (WT) (Figure 2D) or complete
absence of TNF production by F4/80 cells (Figure 2E). induced acute systemic toxicity in mice (Tracey et al.,
1987).CD11bCD11cmyeloid DC from peritoneal cavity were
still able to produce TNF, despite marked deletion of Importantly, serum TNF levels were dramatically re-
duced in MN-TNF KO mice injected with LPS (althoughthe TNF gene in this particular subset of DC (Clausen et
al., 1999). Bone-marrow-derived dendritic cells (BMDC), still clearly exceeding the levels in TNF KO mice), while
they did not differ from the wild-type levels in T-TNF KOwhich are also of monocyte origin, showed partial dele-
tion of the TNF gene (see Supplemental Figure S2). and B-TNF KOmice (Figure 3A). Additionally, quantifica-
tion of soluble TNF protein by ELISA in supernatants ofTherefore, MN-TNF KO mice may serve as a model with
a remarkably complete ablation of TNF in macrophages BMDM stimulated with various pathogen-derived com-
pounds confirmed that TNF production was decreasedand neutrophils.
We next generated T-TNF KO mice using CD4-Cre at least 100-fold in macrophages fromMN-TNF KOmice
(Figure 3B).transgenic mice (Lee et al., 2001). Both Southern analy-
Figure 1. Generation of a Panel of Mice with Cell-Type-Specific TNF Ablation
(A) Targeting strategy and breeding scheme. TNFflox/flox mice were crossed with appropriate Cre-bearing deleter in order to obtain mice with
cell-type-specific TNF deficiencies.
(B) Deletion of the TNF gene in BMDM. DNA was prepared from adherent 10-day BMDM cultures from MN-TNF KO mice and subjected to
Southern analysis (represents one of two independent experiments).
(C) Deletion of the TNF gene in neutrophils. DNA was prepared from FACS-sorted CD11b GR1high cells from thioglycollate-elicited peritoneal
cells (PEC) from MN-TNF KO mice and subjected to Southern analysis.
(D) Multiple tissue analysis of TNF deletion in MN-TNF KO mice. Genomic DNA from various tissues was prepared and subjected to Southern
analysis. PEC were induced by injection of 3% thioglycollate medium i.p. 36 hr before cell collection (represents one of two independent experi-
ments).
(E) T-cell-specific deletion of TNF. Genomic DNA from different tissues and sorted CD3 splenocytes from T-TNF KO mice was purified and
subjected to Southern analysis (represents one of two independent experiments).
(F and G) B-cell-specific inactivation of TNF. Genomic DNA samples from sorted splenic B cells (F) or from various tissues (G) of B-TNF KO
mice were purified and subjected to Southern analysis.
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Figure 2. Efficiency of TNF Ablation in MN-TNF KO and T-TNF KO Mice
(A) TNF mRNA expression in BMDM from MN-TNF KO mice. BMDM were activated by LPS (100 ng/ml) for 1.5 hr, collected, and lysed for
RNA preparation.
(B) TNF production by LPS-activated neutrophils. FACS-sorted CD11b GR1high cells from PEC of MN-TNF KO mice were activated by LPS
(100 ng/ml) for 4 hr.
(C) TNF production by LPS-stimulated PEC. PEC of MN-TNF KO mice were activated by LPS (100 ng/ml) for 6 hr. In (B) and (C), TNF was
measured in supernatants by ELISA (represents one of two independent experiments).
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Figure 3. Macrophages and Neutrophils Are the Main Source of Systemic TNF after LPS Challenge
(A) Systemic TNF production induced by LPS. Mice were injected intraperitoneally with 100 g of LPS, and sera were collected 1.5 hr after
injection. TNF in sera was measured by ELISA (represents one of two independent experiments).
(B) TNF production by BMDM of MN-TNF KO mice. Adherent cells from 10 day cultures (106 cells/ml) were activated for 24 hr in 96-well plates
with LPS (100 ng/ml), bacterial lipoprotein (BLP) (500 ng/ml), CpG (1 ng/ml), HKLM (moi 100:1), or incubated without stimulation in the presence
of IFN (50 ng/ml). TNF production was assessed by ELISA.
(C) Deletion of TNF in macrophages and neutrophils rescues mice from LPS/D-Gal toxicity. Mice were injected intraperitoneally with 10 g
LPS and 20 mg D-Gal, monitored for survival, and sacrificed when moribund (represents one of three independent experiments).
Since both TNF- and TNFR1-deficient mice are com- TNF from Macrophages and Neutrophils Is Critical
for Protection against Listeria, but at High Dosespletely resistant to LPS/D-Gal lethal toxicity (Pfeffer et
T-TNF Becomes Importantal., 1993; Rothe et al., 1993; Pasparakis et al., 1996;
Host defense is one of the complex physiological func-Marino et al., 1997), we asked whether the loss of TNF
tions in which the beneficial and protective role of TNFproduction by macrophages/neutrophils was sufficient
produced by hematopoietic cells has been clearly dem-to protect mice from the septic shock. Remarkably,
onstrated using mice deficient in either TNF or in itsMN-TNF KO mice were completely resistant to this type
main receptor, TNFR1 (Pfeffer et al., 1993; Rothe et al.,of lethal challenge (Figure 3C). On the contrary, mice
1993; Pasparakis et al., 1996;Marino et al., 1997). Never-with lymphocyte-restricted TNF deficiency died with the
theless, the cellular sources of protective TNF are in-same kinetics as thewild-type controls (Figure 3C). Even
completely defined. In order to evaluate the relativelower doses of LPS (1 g) in combination with D-Gal
contribution of macrophages/neutrophils versus lym-were still lethal for T-TNF KO, B-TNF KO, and control
phocytes in TNF production in response to intracellularmice,whereasMN-TNFKOmice remained fully resistant
bacterial infection, we used a Listeria monocytogenes(data not shown). Therefore, for the LPS/D-Gal-induced
model. Inactivation of the TNF gene only in macro-toxic shock, the deleterious role of TNF is solely due to
phages and neutrophils was sufficient for almost com-its production by neutrophils and macrophages.
plete loss of resistance against Listeria, similar to that
In another model of toxic shock induced by superanti-
observed in TNF KO (Figure 4). Indeed, MN-TNF KO
gen from gram-positive bacteria (S. aureus enterotoxin mice developed uncontrolled infection, leading to death
B [SEB]) in the presence of D-Gal, T-TNF KO and within 4 days (Figure 4A) and accompanied by a 3–4 log
MN-TNF KO mice showed a level of protection almost increase in bacterial load, both in the liver and the spleen
identical to that of TNF KO mice, while B-TNF KO mice (Figures 4B and 4C). Under the same conditions,WT and
remained as sensitive as wild-type mice (Supplemental B-TNF KO mice could successfully control the infection
Figure S6). These results implied nonredundant critical (Figures 4C and 4D). While WT mice displayed almost
functions of both T-cell-derived TNF and macrophage/ normal liver histology with only small inflammatory foci,
neutrophil-derived TNF in the development of superanti- TNF KO and MN-TNF KO mice developed large, conflu-
gen-induced shock. Collectively, the data demonstrate ent inflammatory necrotic areas with many Mac-1- and
that the source of deleterious TNF during the develop- Gr1-positive cells,which appeared less abundant in T-TNF
ment of systemic toxicity can be attributed to distinct KO mice and rare in WT mice (Figure 4E). Importantly,
types of leukocytes, and it also depends on the nature induction of the chemokine MCP-1 was reduced in
spleens of MN-TNF KO mice, although not to the extentof the pathogenic stimulus that triggers the response.
(D and E) Intracellular TNF staining of LPS-stimulated PEC. PEC were elicited from MN-TNF KO mice 48 hr (D) or 80 hr (E) after thioglycollate
injection. Cells were activated by LPS (100 ng/ml) for 5 hr and stained for intracellular TNF and forCD11b, CD11c (D), or F4/80 (E) surfacemarkers.
(F) Intracellular labeling for TNF. Splenocytes were activated by 100 ng/ml PMA and 1 g/ml of ionomycin for 5 hr, and intracellular labeling
for TNF and surface markers was performed.
(G) ELISA quantification of IL6 and TNF in the supernatants of BMDC of T-TNF KO and MN-TNF KO mice. BMDC were stimulated by LPS in
the presence of 10 ng/ml IFN  for 24 hr.
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Figure 4. Role of T-Cell-Derived TNF and
Macrophage/Neutrophil TNF in the Resis-
tance against Listeria
(A) Mice were injected intravenously with 5
104 cfu (colony-forming units) of live Listeria,
monitored for survival daily, and sacrificed
whenmoribund (represents one of three inde-
pendent experiments, 5–10 mice per group).
(B–D) Bacterial loads in the liver (B, D) and
spleen (C) of infected mice. Mice were in-
jected intravenously with 5  104 cfu of live
Listeria and sacrificed on day 2, 4, and 7 (D).
Livers and spleens were aseptically removed
and homogenized in sterile PBS with 0.05%
of Tween 20. Serial dilutions were plated into
the brain-heart infusion agar and colony-
forming units were calculated after 24 hr of
growth at 37C (represents one of two inde-
pendent experiments).
(E) Histological examination of liver. Mice
were injected intravenously with 5  104 cfu
of live Listeria and sacrificed on day 3. Livers
were excised and embedded into the O.C.T.
compound for the preparation of frozen sec-
tions or fixed in 10% neutral buffered forma-
lin. Upper panel, hematoxilin/eosin staining
of formalin-fixed paraffin-embedded liver tis-
sue; lower panel, serial frozen liver sections
stained with CD11b and GR1. Original magni-
fication, 100.
(F) Mice were injected intravenously with 5 
103 cfu of live Listeria, monitored for survival
daily, and sacrificed when moribund (repre-
sents one of two independent experiments,
5–10 mice per group).
(G) TNF levels in serum of infected mice. After
high dose of Listeria injection (5  104 cfu
i.v.), mice were bled on day 2 and serum TNF
levels were determined by ELISA.
observed in TNF KO mice (Supplemental Figure S3). could not be detected in MN-TNF KO mice, but TNF
was clearly present in both T-TNF KO and WT miceMCP-1 and its receptor CCR2 are important for resis-
tance against Listeria (Kurihara et al., 1997; Serbina et (Figure 4G).
Interestingly, T-TNFKOmice exhibited increased sen-al., 2003). Although myeloid DC displayed partial dele-
tion of the TNF gene, they were able to produce normal sitivity to Listeria at high doses of infection too, although
the effects weremodest in comparisonwithMN-TNFKOamounts of IL-6, bactericidal nitric oxide, and only
slightly decreased amounts of TNF in vitro (Figure 2G mice (Figure 4A). Specifically, T-TNF KO mice showed
increased mortality, occurring on days 5–8 post infec-and data not shown), implying that the DC-mediated
innate immune component was not severely affected in tion. Bacterial loads in infected organs at the earliest
stages in T-TNF KO mice were comparable with thoseMN-TNFKOmice. SerumTNF levels onday 2of infection
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in WT mice but elevated on day 4 or 6 (Figures 4B–4D). Discussion
However, all surviving T-TNF KOmice were able to clear
Listeria, as no bacteria were detected in organs of mice For many years, TNFwas viewed as a soluble proinflam-
on day 14 (data not shown). This result implied that matory cytokine produced by leukocytes of the innate
T-cell-derived TNF possesses a distinct function in host immunity arm, such as macrophages and neutrophils
defense: protection against high bacterial load, which (Giroir et al., 1992). However, TNF is expressed in both
cannot be provided solely by innate mechanisms. How- soluble and membrane-bound forms by various cell
ever, low-to-moderate doses of infection could be fully types with distinct homing and migratory properties
controlled in T-TNF KO mice, in contrast to MN-TNF (Sedgwick et al., 2000). Thus, different cell subsets are
KO or TNF KO mice (Figure 4F and data not shown). likely to be responsible for systemic versus local TNF
Therefore, the dominant role in production of protective production as well as for TNF-mediated responses in
TNF during Listeria infection is played by macrophages different physiological conditions. In this study, we em-
and neutrophils, while TNF-producing T cells may con- ployed a novel panel of mice with highly specific and
stitute the second line of defense. efficient deletion of TNF gene in several types of leuko-
Interestingly, generation of T cell response and of cytes, including cells of both the innate arm of the im-
T cell memory per se appeared TNF independent, since mune response, such as macrophages and neutrophils,
MN-TNF KO, T-TNF KO, and even TNF KO mice immu- and of its adaptive arm, T and B lymphocytes. Using
nized with ActA-deficient Listeria (Kocks et al., 1992) these tools, we determined the source of TNF produc-
were all able to control and survive secondary challenge tion critical for host defense and for the development
with virulent Listeria (Supplemental Figure S5A). of several TNF-dependent pathologies. Our findings
clearly demonstrate that both macrophage/neutrophil-
derived and T-cell-derived TNF play distinct biologicalBoth T Cells and Macrophages/Neutrophils Produce
TNF that Promotes a Model Autoimmune Disease roles that can be either protective or deleterious. TNF
from these two sources cannot substitute for each other,Despite its beneficial role in providing resistance against
various pathogens, TNF is involved in the development and they cannot be substituted by other cellular sources
of TNF.of inflammatory and autoimmune conditions, such as
RA, brainmalaria, encephalomyelitis, and hepatitis. Ear- Macrophages and neutrophils are the main source of
systemic TNF in vivo in response to LPS during gram-lier studies suggested thatmost of the TNF in the experi-
mental model of autoimmune liver injury, induced by negative sepsis (Figure 3). However, TNF produced both
by T cells and by macrophages/neutrophils in responseConcanavalin A (ConA) (Tiegs et al., 1992), was pro-
duced by resident liver macrophages (Kuppfer cells) to SEB, a toxin derived from gram-positive bacteria, was
responsible for toxicity in SEB/D-Gal shock. In SEB-(Schumann et al., 2000). However, in addition to TNF,
Kuppfer cells can also produce iNOS and several che- induced systemic toxicity, T cells are responsible for
the induction of disease, whereas the non-T cell com-mokines, which are known to be critical for the develop-
ment of hepatitis (Sass et al., 2001). Moreover, develop- partment (presumably, macrophages) is linked to dis-
ease susceptibility and to organ failure (Anderson andment of autoimmune liver injury also requires T cells
that are the primary targets for ConA action. Tary-Lehmann, 2001). Ablation of transcriptional factor
NFATp, which drives TNF expression specifically inIn order to unveil the sources of TNF during the initia-
tion and development of liver injury, we evaluatedConA- T cells, is sufficient for significant protection against
SEB/D-Gal shock (Tsytsykova and Goldfeld, 2000).induced autoimmune hepatitis in a panel of conditional
TNF KO mice (Figure 1). Strikingly, T-TNF KO mice Thus, both T cells (believed to be the primary TNF pro-
ducers in this case) and macrophages make TNF thatshowed increased resistance to the liver injury compara-
ble to that of complete TNF KO mice, implying a critical plays nonredundant critical roles in pathophysiological
consequences of exposure to a superantigen.role of T cells as TNF producers in this model of liver
toxicity (Figures 5A–5C). Inactivation of TNF in macro- From the response to bacterial products, we extended
our studies to a model of intracellular infection. Resis-phages and neutrophils in MN-TNF KO mice also re-
sulted in a similar protection (Figures 5A–5C). tance to listeriosis is a complex reaction by the host
mediated by various cell types: macrophages, neutro-Alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) liver enzyme activities measured in phils, DC, NK cells, and T cells (Edelson and Unanue,
2000; Kaufmann, 1993; Unanue, 1997). These leukocytessera correlated with the extent of liver injury and were
greatly elevated in WT mice or B-TNF KO mice, while produce proinflammatory cytokines such as TNF and
IFN, which are absolutely critical for protection (Pas-in T-TNF KO, MN-TNF KO, and TNF KO mice these
levels remained comparatively low (Figures 5B and 5C). parakis et al., 1996; Pfeffer et al., 1993; Harty and Bevan,
1995). We show here that macrophages and neutrophilsAdditionally, extensive liver necrosis was observed in
WT and B-TNF KO, whereas in T-TNF KO, MN-TNF KO, are critical TNF producers required for the resistance
against the intracellular bacterial pathogen Listeria.and TNF KO only infiltrating cells but no necrosis or
tissue destruction areas could be detected (Figure 5D). These cells of the innate immunity arm represent the
first line of host defense against intracellular pathogens.TNF serum levels correlated well with biochemical and
histological parameters: grossly elevated in both wild- They produce large amounts of TNF (Figures 3A, 3B, and
4G), contributing to both the initial activation of innatetype and B-TNF KO mice and significantly decreased in
both T-TNF KO and MN-TNF KO mice (Figure 5E). Thus, immune response and to the recruitment of DC and
inflammatory cells to the sites of infection. In the ab-ablation of TNF in either T cells or macrophages/neu-
trophils is sufficient to provide significant protection sence of TNF from macrophages and neutrophils, ex-
pression levels of key chemokineMCP-1, which attractsagainst experimental autoimmune hepatitis.
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Figure 5. T-Cell- and Macrophage-Derived TNF Promote Autoimmune ConA-Induced Hepatitis
(A) ConA-induced fulminant liver pathology. Mice were injected intravenously with 15 mg/kg body of ConA. Ten hours later, mice were
sacrificed and the extent of hepatitis was analyzed by a pathologist using a semiquantitative scale of clinical scores as follows: 1–2, normal
liver; 3, mild hepatitis; 4, pronounced hepatitis; 5, severe hepatitis (represents one of two independent experiments).
(B and C) Alanine-aminotransferase (ALT) and aspartate-aminotransferase (AST) activity after ConA injection. Mice were injected intravenously
with 15 mg/kg body of ConA. Sera were collected 10 hr after the injection, and ALT (B) or AST (C) activities were analyzed using an enzymatic
colorimetric kit (represents one of two independent experiments).
(D) Histological examination of liver. Mice were injected intravenously with 15 mg/kg of ConA and sacrificed after 10 hr. Livers were excised
and fixed in 10% neutral buffered formalin, followed by staining of 5 m thick sections with hematoxilin/eosin and visualization with a
photomicroscope. Original magnification: 100 or 200.
(E) Serum levels of TNF after ConA administration. Serum samples were taken 2 hr after ConA injection (15 mg/kg) and analyzed by ELISA.
monocytes and DC to the infected organs, are signifi- elevated on day 4 or 6 (Figures 4B–4D), especially in
mice succumbing to infection (data not shown). At lowercantly reduced (Supplemental Figure S3).
However, despite the apparent lack of contribution doses, T-TNF KOmice were able to control the infection
without increasedmortality (Figure 4F), implying the pre-from T cells to systemic TNF levels in response to bacte-
ria, T-TNF KO mice exhibited increased sensitivity to dominant and sufficient role of macrophage/neutrophil-
derived TNF in protection. Previous studies utilizinghigh dose of Listeria infection, implying that T-cell-
derived TNF is important for controlling the infection at SCID (Bhardwaj et al., 1998) and T-cell-deficient mice
(DiTirro et al., 1998) showed that T cells play a pivotal rolehigh bacterial loads. In T-TNF KO mice, bacteria num-
bers in infected organs at earliest stages of infection in producing sterilizing immunity primarily by several
distinct mechanisms: direct lysis of infected cells bywere comparable with those in WT mice but became
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Table 1. Role of TNF Produced by Distinct Types of Leukocytes in Various Pathophysiological Models
TNF-Producing Cells
TNF-Dependent Feature Macrophages Neutrophils T Cells B Cells
Resistance to intracellular pathogen    no role
Septic (LPS-induced) shock 			 			 no role no role
Superantigen shock 		 no role? 			 no role
Autoimmune hepatitis 			 no role? 			 no role
Lymphoid organ structure no role no role  
Protective () and detrimental (	) effects of TNF produced by various types of leukocytes in host defense against intracellular pathogens,
maintenance of lymphoid organs, toxic shock conditions, and autoimmune hepatitis. Our data suggest that blockade of T-cell-derived TNF
only may neutralize the destructive and toxic TNF in autoimmunity, with only minimal effects on host defense, lymphoid organ structure and
antibody production.
CD8 T cells and by production of IFN (Harty and ConA-induced hepatitis, TNF is a critical mediator of
inflammation and liver destruction (Leist et al., 1996).Bevan, 1995). Both CD4 and CD8 antigen-specific
T cells are known to produce large amounts of TNF Liver macrophages, T cells, NK cells, and neutrophils
were found to be important for the development of hepa-involved in direct killing as well as in activation of inflam-
matory response. For example, lung inflammation and titis onset (Muhlen et al., 2004; Schumann et al., 2000;
Tiegs et al., 1992; Bonder et al., 2004), with membrane-injury in transgenic mice was recently shown to be in-
duced by TNF exclusively expressed by CD8 T cells bound TNF playing a particularly critical role (Maeda et
al., 2003). We found that the deletion of the TNF genewithout any appreciable contribution frommacrophages
(Xu et al., 2004).Mice lacking-T cells rapidly succumb either exclusively in T cells or exclusively in macro-
phages/neutrophils could lead to protection againstto high-dose Listeria infection within 5 days (DiTirro et
al., 1998), while SCID mice are able to control low-dose ConA-induced liver toxicity (Figure 5). This finding leads
to the conclusion that both TNF-producing cell popula-Listeria infection but fail to clear it (Bhardwaj et al., 1998).
There are at least two possible explanations for why tions contribute to liver damage. Since the depletion
of Kuppfer macrophages protects mice from fulminantT-cell-derived TNF may play a unique role in a high-
dose infection model. First, it is conceivable that at least hepatitis and diminishes TNF production (Schumann et
al., 2000), it is likely that the macrophage-derived TNFsome TNF provided by T cells is retained on the mem-
brane of T cells and acts via direct cell-to-cell contact is critical for ConA-induced pathology. However, the
contribution from neutrophil-derived TNF cannot be ex-(Kinkhabwala et al., 1990; Grell et al., 1995), i.e., upon
antigen recognition. Indeed, mice bearing a noncleav- cluded (Bonder et al., 2004). Since ConA primarily tar-
gets T cells and not macrophages, our findings stronglyable form of TNF showed a partial protection against
mycobacteria (Olleros et al., 2002) or Listeria (Paspar- argue that, in addition to its possible direct hepatotoxic-
ity, T-cell-derived TNF participates in activation of mac-akis et al., 1996). Membrane-bound TNF apparently can-
not be substituted by TNF from other sources and can rophages. TNF can also induce upregulation of adhesion
molecules, which is necessary for the recruitment ofactivate downstream chemokines differently from the
soluble TNF (Ruuls et al., 2001). Alternatively, activated immune cells to the liver and for the development of
hepatitis. Cooperation between T cells and liver macro-T cells secrete TNF, which nevertheless remains in tight
contact with target cell inside the immunological syn- phages during cocultivation in vitro resulted in the in-
creased production of cytokines, particularly TNF, com-apse, without further diffusion. Finally, in the course of
infection, TNF production by innate immune cells may pared to what each of these cell types produced alone
(Gantner et al., 1996). Interestingly, deregulation of TNFbe downregulated, thus leaving TNF produced by T cells
indispensable for the further recruitment and activation expression either in T cells or in macrophages in Crohn-
like disease was also sufficient to induce organ inflam-of inflammatory cells. Additional studies are needed to
shed more light on the mechanisms of T-cell-derived mation and development of disease onset (Kontoyiannis
et al., 2002).TNF function in the resistance to intracellular pathogen.
One might expect that the role of TNF from T cells is Overall, this study hasdissected someof the functions
of TNFproducedby individual typesof leukocytes in vivoeven more pronounced in long-term infections, as was
recently shown for mycobacteria (Saunders et al., 2004). (Table 1). Our datademonstrate thedistinct andnonredun-
dant functions of TNF produced by macrophage/neutro-TNF has been clearly implicated in the pathogenesis
of several autoimmune diseases, such as autoimmune phils and by T cells in autoimmune hepatitis, superanti-
gen-induced shock, and resistance against intracellulardiabetes, RA, psoriasis, and encephalomyelitis, often
causing deleterious effects. In humans, continuous TNF pathogens (Listeria). Interestingly, no role in toxicity,
host defense, or autoimmunity has been attributed soblockade by injectable TNF inhibitors is the widely ac-
cepted treatment of autoimmune disease, such as RA far to B-cell-derived TNF, although it was clearly impli-
cated in the maintenance of the secondary lymphoid or-(Feldmann, 2002) andpsoriasis. Howefficiently TNFpro-
duced by each individual subset of leukocytes in vivo gans’ structure (Endres et al., 1999; Wang et al., 2001;
Tumanov et al., 2004). A panel of mice with targetedcan be blocked during these treatments remains to
be determined. cell-type-specific inactivation of TNF will serve in the
future for studying the role of TNF in the development ofIn an experimentalmodel of autoimmune liver disease,
Immunity
102
cells/ml) were stimulated in 96-well plates with LPS (100 ng/ml;various autoimmune disorders, including inflammatory
Sigma), bacterial lipoprotein (BLP) (500 ng/ml), CpG (1 ng/ml), orbowel disease and arthritis.
HKLM (moi 100:1).Thus, individual subsets of immune cells can produce
both “good” TNF, protecting against intracellular patho-
RNA Analysis
gens, and “bad” TNF, contributing to autoimmune de- RNA from infected organs was prepared using Tri-Reagent (Sigma),
struction of tissues. Nevertheless, our data strongly im- then treated with DNase I (Promega) and reversely transcribed using
ply that if blockade of TNF production is restricted to ImProm-II Reverse Transcription System (Promega). For Taqman
real-time PCR analysis of MCP-1, the following oligonucleotidesT cells, it may neutralize deleterious effects associated
were used: forward primer 5




-FAM CTCAGCprotective functions necessary for host defense (Table
CAGATGCAGTTAACGCCCC-TAMRA.
1). Given that the kinetics and absolute levels of TNF
production are controlled differently in macrophages, Immunohistochemistry
T cells, and other cell types (both at transcriptional and Immunohistochemistry was performed on frozen sections of 7 m
posttranscriptional levels), it is likely that future thera- thickness, fixed in acetone as previously described (Tumanov et al.,
2002). See Supplemental Experimental Procedures for the list ofpeutic strategies using these differences to inhibit TNF
primary rat anti-mouse monoclonal antibodies used. For routinemadeby Tcellsmay findmorebeneficial clinical applica-
histology, tissues were fixed in 10% neutral formalin, embeddedtions compared to systemic TNF blockade.
into paraffin, and 5 m sections were prepared and stained with
hematoxilin and eosin.
Experimental Procedures
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marker staining was performed according to the manufacturer’stargeted ES cell clone #6537 (see Supplemental Experimental Pro-
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